Besides, ccRCC4 tumors showed no response to sunitinib, which was related to high levels of expression of markers of Tregs (i.e., FOXP3, IL-10., and TGF-). optimization of combination therapy and development of individualized therapy for advanced ccRCC. = 0.0001) and objective response rates (ORR) (31 vs. 13%; = 0.0001), and did not lead to significantly … Continue reading Besides, ccRCC4 tumors showed no response to sunitinib, which was related to high levels of expression of markers of Tregs (i